Terns Pharmaceuticals, Inc. (TERN)
44.56
+2.00
(+4.69%)
USD |
NASDAQ |
Dec 10, 16:00
44.61
+0.04
(+0.10%)
After-Hours: 20:00
Terns Pharmaceuticals Research and Development Expense (Quarterly): 19.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Pfizer Inc. | 2.492B |
| Altimmune, Inc. | 14.93M |
| Viking Therapeutics, Inc. | 89.95M |
| Rhythm Pharmaceuticals, Inc. | 45.92M |